Pradaxa® now available in UK for treatment of DVT and PE
Boehringer Ingelheim has announced that Pradaxa® will be commercially available in the UK for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of it's recurrence, from July 14th.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Cardiovascular medicine Haematology Latest News Source Type: news
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Pulmonary Thromboembolism | Thrombosis